search
Back to results

Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training (ENERGETIC)

Primary Purpose

Readaptation to Effort, Coronaropathy, Chronic Obstructive Pulmonary Disease

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
conventional rehabilitation program (including concentric cycle ergometer)
cycling included into a conventional rehabilitation program
Sponsored by
Centre Hospitalier Universitaire Dijon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Readaptation to Effort

Eligibility Criteria

40 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Persons who have provided written informed consent

Healthy volunteers:

  • Men or women aged between 40 and 75 years.

Patients with CAD:

  • Men or women aged between 40 and 75 years, with coronary artery disease without heart failure referred for a rehabilitation program.
  • Left ventricular ejection fraction on echocardiography (Simpson methode) > 45 %

Patients with Chronic obstructive pulmonary disease:

  • Men or women aged between 40 and 75 years
  • Severe Chronic obstructive pulmonary disease (post-bronchodilatator FEV1/FVC < 0.70 and FEV1 ≤ 60% of predicted value)
  • Patient not on oxygen therapy (24h/24)

Exclusion Criteria:

  • Person without national health insurance cover
  • Severe, obstructive cardiopathy
  • Severe aortic valve stenosis,
  • Severe progressive heart rhythm or conduction disorders not corrected by a pacemaker and detected during the initial effort test
  • Cardiac intracavitary thrombus,
  • Severe pulmonary artery hypertension (PAHT systolic >70mmHg),
  • Recent history of venous thromboembolism (previous 3 months),
  • Impaired executive functions making it impossible to understand and adhere to a rehabilitation program (Mini Mental Test < 24),
  • Heart transplant,
  • Associated medical condition that could substantially affect functional capacities (examples: non-stabilized metabolic disorders such as progressive renal insufficiency, major asthenia linked to a severe non-stabilized disorder such as neoplasia, systemic disease…).
  • Physical incapacity of the lower limbs that could impair rehabilitation, whether they are neurological (central or peripheral), arterial (in particular, peripheral artery disease with a systolic index < 0.6) or orthopedic (degenerative or inflammatory rheumatism).
  • Patients who have taken part (within the previous 6 months) or a currently taking part in a rehabilitation program.

Sites / Locations

  • CHU de BESANCON
  • CHU de DIJON

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

"Conventional" group

"Combined" group

Arm Description

Outcomes

Primary Outcome Measures

For patients with CAD: Distance covered during a 6-minute walk test and triceps surae maximal isometric force
For COPD patients : Endurance time at 75 % of peak workload achieved on a cycle ergometer during the initial concentric cardiopulmonary exercise test (CPET)

Secondary Outcome Measures

For CAD patients: Functional Independence Measure
For CAD patients: Timed up and go test
For CAD patients: Step test with gas exchange measurement
For CAD patients: Distance covered in the 6-minute walk test
For CAD patients: peak VO2 and 1st ventilation adaptation threshold
For CAD patients: VO2 measurement during the 6 minute walk test
For CAD patients: heart rate and systolic blood pressure
For CAD patients: cardiac output measured non-invasively
For CAD patients: maximum isometric muscle strength of the triceps and quadriceps
For CAD patients: tissue oxygenation measured by infrared spectroscopy (non-invasive) at the quadriceps
For CAD patients: reaction hyperaemia in the circumflex humeral artery mesured by ultrasound
For CAD patients: Measurement of lactates
For COPD patients: Distance covered in the 6-minute walk test
For COPD patients: peak VO2 and 1st ventilation adaptation threshold
For COPD patients: SpO2 and heart rate measurement before, during and after the 6-minute walk test
For COPD patients: SpO2 measurement and heart rate during the sessions (warm-up, end of session)
For COPD patients: maximum isometric muscle strength of the quadriceps
For COPD patients: arterial compliance (pulse wave velocity measurement)
For COPD patients: Measurement of lactates
For COPD patients: muscle composition and vascularization through muscle biopsies (optional)
For COPD patients: St George's Respiratory Questionnaire (SGRQ)
For COPD patients: Quality of life-BPCO (VQ11)
For COPD patients: COPD Assessment Test (CAT)
For COPD patients: BDI/TDI and mMRC dyspnea assessment

Full Information

First Posted
March 5, 2014
Last Updated
July 19, 2019
Sponsor
Centre Hospitalier Universitaire Dijon
search

1. Study Identification

Unique Protocol Identification Number
NCT02156245
Brief Title
Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training
Acronym
ENERGETIC
Official Title
Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
September 16, 2013 (Actual)
Primary Completion Date
April 3, 2019 (Actual)
Study Completion Date
April 3, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire Dijon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aim of this study is to assess the efficacy of a rehabilitation protocol based on individualized combined eccentric and concentric cycle ergometer training compared to classical concentric cycle training among patients with either coronary artery disease (CAD) or chronic obstructive pulmonary disease (COPD). This study will therefore evaluate the efficacy of combined eccentric/concentric training on physical capacity and overall autonomy, and will analyse the adaptive mechanisms with regard to both adaptation to cardiac and muscular effort and tolerance.
Detailed Description
The research will take place in 3 phases: PHASE 1 : 30 healthy volunteers will be included to test tolerance to personalized exercise on an eccentric cycle ergometer. PHASE 2 : 15 patients suffering from coronary artery disease (CAD) and 15 patients suffering from chronic obstructive pulmonary disease (COPD) will be included to test the same protocol. PHASE 3 : A total of 169 patients split into 2 parallel groups will be included: a group receiving conventional rehabilitation (group A) and the other group receiving eccentric exercise combined to conventional rehabilitation (group B). Coronary patients: 93 patients will be included (62 patients in group A and 31 in group B). COPD patients: 76 patients will be included (38 patients per group).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Readaptation to Effort, Coronaropathy, Chronic Obstructive Pulmonary Disease

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
212 (Actual)

8. Arms, Groups, and Interventions

Arm Title
"Conventional" group
Arm Type
Experimental
Arm Title
"Combined" group
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
conventional rehabilitation program (including concentric cycle ergometer)
Intervention Type
Other
Intervention Name(s)
cycling included into a conventional rehabilitation program
Primary Outcome Measure Information:
Title
For patients with CAD: Distance covered during a 6-minute walk test and triceps surae maximal isometric force
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients : Endurance time at 75 % of peak workload achieved on a cycle ergometer during the initial concentric cardiopulmonary exercise test (CPET)
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Secondary Outcome Measure Information:
Title
For CAD patients: Functional Independence Measure
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: Timed up and go test
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: Step test with gas exchange measurement
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: Distance covered in the 6-minute walk test
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: peak VO2 and 1st ventilation adaptation threshold
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: VO2 measurement during the 6 minute walk test
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: heart rate and systolic blood pressure
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: cardiac output measured non-invasively
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: maximum isometric muscle strength of the triceps and quadriceps
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: tissue oxygenation measured by infrared spectroscopy (non-invasive) at the quadriceps
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: reaction hyperaemia in the circumflex humeral artery mesured by ultrasound
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For CAD patients: Measurement of lactates
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: Distance covered in the 6-minute walk test
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: peak VO2 and 1st ventilation adaptation threshold
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: SpO2 and heart rate measurement before, during and after the 6-minute walk test
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: SpO2 measurement and heart rate during the sessions (warm-up, end of session)
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: maximum isometric muscle strength of the quadriceps
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: arterial compliance (pulse wave velocity measurement)
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: Measurement of lactates
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: muscle composition and vascularization through muscle biopsies (optional)
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: St George's Respiratory Questionnaire (SGRQ)
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: Quality of life-BPCO (VQ11)
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: COPD Assessment Test (CAT)
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Title
For COPD patients: BDI/TDI and mMRC dyspnea assessment
Time Frame
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Persons who have provided written informed consent Healthy volunteers: Men or women aged between 40 and 75 years. Patients with CAD: Men or women aged between 40 and 75 years, with coronary artery disease without heart failure referred for a rehabilitation program. Left ventricular ejection fraction on echocardiography (Simpson methode) > 45 % Patients with Chronic obstructive pulmonary disease: Men or women aged between 40 and 75 years Severe Chronic obstructive pulmonary disease (post-bronchodilatator FEV1/FVC < 0.70 and FEV1 ≤ 60% of predicted value) Patient not on oxygen therapy (24h/24) Exclusion Criteria: Person without national health insurance cover Severe, obstructive cardiopathy Severe aortic valve stenosis, Severe progressive heart rhythm or conduction disorders not corrected by a pacemaker and detected during the initial effort test Cardiac intracavitary thrombus, Severe pulmonary artery hypertension (PAHT systolic >70mmHg), Recent history of venous thromboembolism (previous 3 months), Impaired executive functions making it impossible to understand and adhere to a rehabilitation program (Mini Mental Test < 24), Heart transplant, Associated medical condition that could substantially affect functional capacities (examples: non-stabilized metabolic disorders such as progressive renal insufficiency, major asthenia linked to a severe non-stabilized disorder such as neoplasia, systemic disease…). Physical incapacity of the lower limbs that could impair rehabilitation, whether they are neurological (central or peripheral), arterial (in particular, peripheral artery disease with a systolic index < 0.6) or orthopedic (degenerative or inflammatory rheumatism). Patients who have taken part (within the previous 6 months) or a currently taking part in a rehabilitation program.
Facility Information:
Facility Name
CHU de BESANCON
City
Besancon
ZIP/Postal Code
25000
Country
France
Facility Name
CHU de DIJON
City
Dijon
ZIP/Postal Code
21079
Country
France

12. IPD Sharing Statement

Learn more about this trial

Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training

We'll reach out to this number within 24 hrs